Understanding how actin dynamics affect Alzheimer's disease progression
Deciphering the Mechanisms and Cellular Roles of Monomer-Driven Actin Dynamics
This study is looking at how changes in the structure of brain cells might contribute to Alzheimer's disease, with the hope of finding new ways to help prevent or reduce memory loss for people affected by this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-10940324 on NIH RePORTER |
What this research studies
This research investigates the role of actin dynamics in the development of Alzheimer's disease, focusing on how disruptions in the neuronal cytoskeleton may lead to cognitive decline. By studying neurons from Alzheimer's mouse models, the researchers aim to identify early pathological events that contribute to neurodegeneration. The approach involves examining the effects of actomyosin on microtubule stability and organelle transport within neurons. If successful, this research could lead to new therapeutic strategies targeting the cytoskeleton to prevent or mitigate Alzheimer's-related damage.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are diagnosed with Alzheimer's disease or exhibit early signs of cognitive decline.
Not a fit: Patients with other forms of dementia or cognitive impairments unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new insights into potential treatments for Alzheimer's disease that target early cellular changes.
How similar studies have performed: While the specific approach of targeting actomyosin in Alzheimer's is novel, similar studies have shown promise in understanding cytoskeletal roles in neurodegenerative diseases.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Vitriol, Eric a — Augusta University
- Study coordinator: Vitriol, Eric a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.